NCT06895980 Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program
| NCT ID | NCT06895980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chile |
| Condition | Periodontitis Chronic Generalized Moderate |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-08-22 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-08-22 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this clinical trial is to evaluate the effect of periodontal treatment on the reduction of glycated hemoglobin levels in adult patients with concurrent type 2 diabetes mellitus and periodontitis. Non-surgical periodontal treatment and the application of a quality of life survey will be performed and then controls will be carried out for 1 year.
Eligibility Criteria
Inclusion Criteria: * 1a. Patients enrolled in the PSCV with a diagnosis of type 2 diabetes mellitus and who, in turn, have a glycated hemoglobin ≥ 7% (during the last 6 months). * 1b. Patients with a diagnosis of periodontitis (≥ 2 non-adjacent teeth with detectable clinical interproximal attachment loss or, attachment loss ≥ 3mm with depth to probing ≥ 3mm on free faces of ≥ 2 teeth, where the attachment loss was not attributed to non-periodontal causes (Papapanou et al., 2018)). Exclusion Criteria: * 2a. Patients who have received periodontal treatment during the last year. * 2b. Pregnancy/lactation, because they are under treatment under the Explicit Health Guarantee "Oral and Integral Health of Pregnant Women". * 2c. Therapy with antibiotics and/or non-steroidal anti-inflammatory drugs (NSAIDs) in the last 6 months prior to the study.
Contact & Investigator
Melisa Vera, Specialist in periodontics
PRINCIPAL INVESTIGATOR
University of Chile
Frequently Asked Questions
Who can join the NCT06895980 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Periodontitis Chronic Generalized Moderate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06895980 currently recruiting?
Yes, NCT06895980 is actively recruiting participants. Contact the research team at mvera@odontologia.uchile.cl for enrollment information.
Where is the NCT06895980 trial being conducted?
This trial is being conducted at Santiago, Chile.
Who is sponsoring the NCT06895980 clinical trial?
NCT06895980 is sponsored by University of Chile. The principal investigator is Melisa Vera, Specialist in periodontics at University of Chile. The trial plans to enroll 80 participants.